17.23
-0.75 (-4.17%)
-0.75 (-4.17%)
Upgrade to Real-Time
Afterhours
Low
1.38
High
30.375
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aclaris Therapeutics Inc | ACRS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.75 | -4.17% | 17.23 | 16:31:44 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 18.10 | 17.19 | 18.21 | 17.23 | 17.98 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 17.23 | 17.45 | 0.22 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,072 | 687,101 | $ 17.63 | $ 12,111,037 | 791,910 | 1.38 - 30.375 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:05:06 | average | 21,546 | $ 17.23 | USD |
Aclaris Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.02B | 59.15M | 50.06M | $ 6.48M | $ - | -1.20 | -12.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 478.41k | 4.60% |
Aclaris Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACRS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 18.32 | 18.69 | 17.19 | 18.06 | 747,490 | -1.09 | -5.95% |
| 1 Month | 21.73 | 24.00 | 16.82 | 19.43 | 982,308 | -4.50 | -20.71% |
| 3 Months | 23.79 | 30.375 | 16.82 | 22.62 | 713,457 | -6.56 | -27.57% |
| 6 Months | 6.94 | 30.375 | 5.65 | 19.60 | 1,828,259 | 10.29 | 148.27% |
| 1 Year | 1.47 | 30.375 | 1.38 | 15.34 | 1,227,794 | 15.76 | 1,072.11% |
| 3 Years | 19.48 | 30.375 | 0.70 | 9.25 | 872,077 | -2.25 | -11.55% |
| 5 Years | 18.09 | 33.25 | 0.70 | 11.66 | 623,578 | -0.86 | -4.75% |
Aclaris Therapeutics Description
| Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are ATI-450, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777. |
